Nexalis Therapeutics Limited (ASX:NX1)
Australia
· Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
At close: Mar 9, 2026
Nexalis Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -1.83 | -1.21 | -1.44 | -1.93 | -1.11 | Upgrade
|
| Depreciation & Amortization | - | - | - | 0.01 | 0 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.01 | - | - | Upgrade
|
| Stock-Based Compensation | - | 0.2 | 0.06 | 0.03 | - | Upgrade
|
| Other Operating Activities | 0.94 | -0.12 | 0 | - | 0 | Upgrade
|
| Change in Accounts Receivable | - | 0.36 | -0.77 | -0.01 | 0.06 | Upgrade
|
| Change in Inventory | - | - | - | 0.02 | -0.02 | Upgrade
|
| Change in Accounts Payable | - | 0.39 | 0.15 | 0.08 | -0.06 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.02 | -0.06 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.01 | 0.03 | -0.01 | 0.04 | Upgrade
|
| Operating Cash Flow | -0.89 | -0.37 | -1.96 | -1.85 | -1.15 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0 | -0.01 | Upgrade
|
| Investing Cash Flow | - | - | - | -0 | -0.03 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.55 | - | - | Upgrade
|
| Long-Term Debt Issued | 1.02 | 0.4 | - | - | - | Upgrade
|
| Total Debt Issued | 1.02 | 0.4 | 0.55 | - | - | Upgrade
|
| Short-Term Debt Repaid | -0.37 | -0.55 | - | - | - | Upgrade
|
| Total Debt Repaid | -0.37 | -0.55 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.65 | -0.15 | 0.55 | - | - | Upgrade
|
| Issuance of Common Stock | 0.54 | - | - | 1.2 | 2.27 | Upgrade
|
| Other Financing Activities | -0.06 | -0.01 | -0 | -0.02 | -0.01 | Upgrade
|
| Financing Cash Flow | 1.13 | -0.15 | 0.54 | 1.18 | 2.26 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | 0.24 | -0.52 | -1.42 | -0.67 | 1.08 | Upgrade
|
| Free Cash Flow | -0.89 | -0.37 | -1.96 | -1.85 | -1.16 | Upgrade
|
| Free Cash Flow Margin | -115.69% | -91.78% | -162.94% | -7444.75% | -638.32% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Cash Interest Paid | - | 0.04 | 0.01 | - | - | Upgrade
|
| Levered Free Cash Flow | -0.49 | -0.1 | -1.59 | -1.08 | -0.97 | Upgrade
|
| Unlevered Free Cash Flow | -0.4 | -0.04 | -1.59 | -1.08 | -0.97 | Upgrade
|
| Change in Working Capital | - | 0.76 | -0.59 | 0.05 | -0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.